Search

Search Results

• TWIST1 Protein Expression in Plasma Cell Neoplasias and Plasmablastic Lymphoma

  Mariya Vladimirovna Melnikova, A.M. Kovrigina, M.V. Soloveva, Yu.A. Chabaeva, S.M. Kulikov, T.N. Obukhova, B.V. Biderman, I.A. Yakutik, A.B. Sudarikov

  70-80

  01.01.2026

• Analysis of Plasma Circulating Cell-Free DNA in Acute Myeloid Leukemia Patients

  Elena Nikolaevna Voropaeva, M.V. Burundukova, I.A. Kuznetsova, P.S. Orlov, A.M. Nesterets, S.V. Minnikh, V.N. Maximov, T.I. Pospelova

  347-354

  01.10.2025

• Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia

  Anastasiya Aleksandrovna Semenova, A.S. Luchinin, A.S. Subbotin, G.S. Tumyan, A.V. Arakelyan, A.I. Cherencova, S.S. Kamyshanov

  388-394

  01.10.2025

• The Prognostic Value of the Galectin-1 Expression by Tumor Plasma Cells and the Concentration of Some Serum Cytokines (IL-2, IL-6, TNF) in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

  Zhanna Mikhailovna Kozich, V.N. Martinkov, D.A. Zinovkin, Zh.N. Pugacheva, N.N. Klimkovich

  65-72

  01.01.2025

• Efficacy and Toxicity of Cytarabine + G-CSF, Cyclophosphamide + G-CSF, and Plerixafor + G-CSF Mobilization of Autologous Hematopoietic Stem Cells in Hematologic Malignancy Patients with Predicted Poor Collection

  Svetlana Sergeevna Elkhova, L.V. Filatova, I.S. Zyuzgin, S.A. Volchenkov, L.A. Kramynin, T.Yu. Semiglazova

  86-91

  01.01.2025

• KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

  Anna Mikhailovna Sergeeva, V.L. Surin, Yu.A. Chabaeva, A.A. Kraizman, M.V. Solovev, S.M. Kulikov, L.P. Mendeleeva

  256-265

  01.07.2024

• Plasmablastic Lymphoma and Plasmablastic Myeloma: А Diagnostic Dilemma (Literature Review)

  Mariya Vladimirovna Melnikova, A.M. Kovrigina

  129-140

  01.04.2024

• Mutation Profile of Normal and Tumor Cells in a Patient with Multiple Myeloma: A Case Report

  A.S. Zhuk, I.I. Kostroma, Elena Igorevna Stepchenkova, D.V. Kachkin, O.B. Belopolskaya, I.V. Zotova, A.D. Garifullin, S.V. Voloshin, S.V. Gritsaev, A.Yu. Aksenova

  337-349

  09.06.2023

• Multiple Myeloma Complicated by Bone Plasmacytomas: Pathogenesis, Clinical Features, Treatment Approaches (A Literature Review)

  Elizaveta Andreevna Mamaeva, M.V. Solov’eva, L.P. Mendeleeva

  303-310

  09.06.2023

• CAR-T Therapy of Multiple Myeloma, Based on the Congresses ASH-2021 and ASCO-2022

  Sergei Vyacheslavovich Semochkin

  1-13

  01.01.2023

• Efficacy of Combined Drug Pre-transplant Conditioning Regimens in Multiple Myeloma Patients with Single Autologous Hematopoietic Stem Cell Transplantation

  Ivan Ivanovich Kostroma, A.S. Zhuk, Zh.Yu. Sidorova, R.R. Sabitova, A.Yu. Aksenova, O.B. Belopolskaya, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  88-95

  01.01.2023

• The Importance of Complementary Immunological Markers in the Diagnosis of Minimal Residual Disease in Multiple Myeloma

  E.E. Tolstykh, O.S. Chuvadar, A.A. Semenova, N.A. Kupryshina, O.P. Kolbatskaya, Yu.I. Klyuchagina, O.A. Kolomeitsev, G.S. Tumyan, Nikolai Nikolaevich Tupitsyn

  388-395

  01.10.2022

• Experimental Study of the In Vitro and In Vivo Functional Activity of NKG2D Chimeric Antigen Receptor

  Kseniya Aleksandrovna Levchuk, S.A. Osipova, A.V. Onopchenko, M.L. Vasyutina, E.R. Bulatov, A.Kh. Valiullina, O.N. Demidov, A.V. Petukhov

  327-339

  01.10.2022

• The Prognostic Value of Immunophenotypic Characteristics of Plasma Cells in Newly Diagnosed Multiple Myeloma Patients Treated with First-Generation Proteasome Inhibitor Bortezomib

  Galina Nikolaevna Salogub, E.B. Rusanova, M.V. Gorchakova, E.A. Belyakova

  377-387

  01.10.2022

• Multiple Myeloma: Nuances of Minimal Residual Disease Diagnosis and Monitoring with the Use of Multicolor Flow Cytometry

  I.V. Galtseva, Kseniya Aleksandrovna Nikiforova, Yu.O. Davydova, N.M. Kapranov, M.V. Solov’ev, E.N. Parovichnikova, L.P. Mendeleeva

  365-376

  01.10.2022

• Stratification of Patients with Multiple Myeloma: State-of-the-Art and Prospects

  Anna Yurevna Aksenova, A.S. Zhuk, E.I. Stepchenkova, S.V. Gritsaev

  259-270

  01.07.2022

• Evaluation of Heterozygosity Loss in STR-Loci of Tumor DNA in Multiple Myeloma Patients with Plasmacytoma Based on the Molecular Analysis of Complex Archival Tumor Samples

  Elena Evgen’evna Nikulina, M.V. Firsova, N.V. Risinskaya, Ya.A. Kozhevnikova, M.V. Solov’ev, T.V. Abramova, T.N. Obukhova, A.M. Kovrigina, A.B. Sudarikov, L.P. Mendeleeva

  156-166

  01.04.2022

• Aldehyde Dehydrogenase as a Marker of Early Mesenchymal Progenitor Cells in Donor Bone Marrow Stroma

  Konstantin Aleksandrovich Vetoshkin, N.V. Isaeva, M.A. Butolina, N.V. Minaeva, N.A. Zorina, M.N. Khorobrykh, Yu.S. Zmeeva

  123-128

  01.04.2020

• Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma

  Maiya Valer’evna Firsova, L.P. Mendeleeva, A.M. Kovrigina, M.V. Solov’ev, N.L. Deineko, M.Yu. Drokov, V.G. Savchenko

  377-384

  01.10.2019

• A Case of Hairy Cell Leukemia Diagnosed Simultaneously with Lymphoplasmacytic Lymphoma by Anti-CD Antibody Microarray Method

  Alina Nikolaevna Khvastunova, L.S. Al-Radi, O.S. Fedyanina, S.A. Lugovskaya, S.A. Kuznetsova

  243-246

  01.07.2019

• Polymerase Chain Reaction for Prognosis Assessment and Monitoring of the Epstein-Barr Virus-Associated Hodgkin’s Lymphoma

  M.A. Katin, Ivan Viktorovich Zhil’tsov, V.M. Semenov, D.K. Novik

  182-186

  01.04.2018

• Plasma cell neoplasms in HIV-Infected Patients: A Literature Review and Case Series

  R.A. Leigton, Aleksandr Vasil’evich Pivnik, E.P. Sergeeva, N.V. Kremneva, O.V. Mukhin

  464-470

  01.10.2017

• Pathological Metabolism of Methionine in Malignant Cells Is a Potential Target for the Antitumor Therapy

  Vadim Sergeevich Pokrovskii, D.Zh. Davydov, N.V. Anufrieva, D.D. Zhdanov, E.M. Treshchalina, T.V. Demidkina, E.A. Morozova

  324-332

  01.07.2017

• Clinical Significance of Immunophenotyping of Bone Marrow Cells in Multiple Myeloma

  Oksana Yur’evna Yakimovich, O.M. Votyakova, N.V. Lyubimova, N.N. Tupitsyn

  296-301

  01.07.2016

• Epstein-Barr Virus and Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevich

  101-114

  01.04.2016

• Role of TGF-b1 Gene Polymorphism in Development of Multiple Myeloma

  Anastasiya Aleksandrovna Pavlova, L.N. Bubnova, Yu.V. Sokolova, E.V. Karyagina, S.S. Bessmel’tsev, I.E. Pavlova

  274-280

  01.07.2015

• Basic mechanisms of angiogenesis in hematological malignancies

  А.А. Vartanyan

  343-353

  01.10.2013

• Multiple myeloma (pathogenesis, clinical features, diagnosis, differential diagnosis). Part I

  S.S. Bessmeltsev

  237-257

  01.07.2013